| 1 | Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses | 1.1 | 85 | Citations (PDF) |
| 2 | Can the prevalence of one STI serve as a predictor for another? A mathematical modeling analysis | 0.8 | 2 | Citations (PDF) |
| 3 | Mindray CL-900i assay: An effective assay for hepatitis B surface antigen screening with superior specificity | 1.1 | 1 | Citations (PDF) |
| 4 | Hepatitis C virus transmission among people who inject drugs in the Middle East and North Africa: mathematical modeling analyses of incidence and intervention impact | 6.6 | 6 | Citations (PDF) |
| 5 | Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron | 30.7 | 54 | Citations (PDF) |
| 6 | Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials | 12.4 | 51 | Citations (PDF) |
| 7 | Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar | 0.7 | 4 | Citations (PDF) |
| 8 | Age-Dependent Assortativeness in Herpes Simplex Virus Type 1 Oral Transmission in the United States: A Mathematical Modeling Analysis | 2.2 | 3 | Citations (PDF) |
| 9 | Prevalence of hepatitis C virus infection in Qatar’s resident population based on a national screening campaign | 2.7 | 1 | Citations (PDF) |
| 10 | Epidemiology of Neisseria gonorrhoeae in South-East Asia: Systematic review, meta-analyses, and meta-regressions | 2.5 | 4 | Citations (PDF) |
| 11 | Immune histories and natural infection protection during the omicron era | 3.1 | 1 | Citations (PDF) |
| 12 | Vaccination as a strategy for Chlamydia trachomatis control: a global mathematical modeling analysis | 1.5 | 6 | Citations (PDF) |
| 13 | The association between previous SARS-CoV-2 infection and incidence of stroke | 1.1 | 1 | Citations (PDF) |
| 14 | Diarrhea in Yemeni children under five: A multi-level analysis of population-based surveys, 1991–2022 | 2.0 | 2 | Citations (PDF) |
| 15 | Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study | 1.7 | 2 | Citations (PDF) |
| 16 | Incorporating Interventions to an Extended SEIRD Model with Vaccination: Application to COVID-19 in Qatar | 0.3 | 2 | Citations (PDF) |
| 17 | Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design | 2.4 | 11 | Citations (PDF) |
| 18 | Epidemiology of gonorrhoea: systematic review, meta-analyses, and meta-regressions, World Health Organization European Region, 1949 to 2021 | 3.4 | 22 | Citations (PDF) |
| 19 | Impact of price reductions, subsidies, or financial incentives on healthy food purchases and consumption: a systematic review and meta-analysis | 9.8 | 60 | Citations (PDF) |
| 20 | SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines | 2.0 | 17 | Citations (PDF) |
| 21 | Understanding dynamics and overlapping epidemiologies of HIV, HSV-2, chlamydia, gonorrhea, and syphilis in sexual networks of men who have sex with men | 1.8 | 16 | Citations (PDF) |
| 22 | Sexually transmitted infections among pregnant Syrian refugee women seeking antenatal care in Lebanon | 2.0 | 5 | Citations (PDF) |
| 23 | Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant | 2.0 | 22 | Citations (PDF) |
| 24 | Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens | 2.0 | 15 | Citations (PDF) |
| 25 | Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination | 2.2 | 2 | Citations (PDF) |
| 26 | Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar | 1.4 | 7 | Citations (PDF) |
| 27 | Prevalence of hepatitis B and C viruses among migrant workers in Qatar | 2.7 | 6 | Citations (PDF) |
| 28 | Comparative analysis and evolution of civilian versus combatant mortality ratios in Israel-Gaza conflicts, 2008–2023 | 1.8 | 8 | Citations (PDF) |
| 29 | Prevalence of hepatitis A virus among migrant workers in Qatar: A national study | 1.5 | 1 | Citations (PDF) |
| 30 | Dynamics of Neisseria gonorrhoeae transmission among female sex workers and clients: A mathematical modeling study | 1.3 | 10 | Citations (PDF) |
| 31 | Epidemiology of herpes simplex virus type 1 in the United States: Systematic review, meta-analyses, and meta-regressions | 2.4 | 24 | Citations (PDF) |
| 32 | Epidemiology of Trichomonas vaginalis infection in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions | 6.6 | 20 | Citations (PDF) |
| 33 | Impact of mitigating obesity, smoking, and physical inactivity on type 2 diabetes mellitus burden in Oman: insights from mathematical modeling | 2.9 | 6 | Citations (PDF) |
| 34 | Epidemiology of gonorrhea in countries of the Middle East and North Africa: systematic review, meta analyses, and meta regressions | 1.5 | 9 | Citations (PDF) |
| 35 | BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar | 2.2 | 7 | Citations (PDF) |
| 36 | Seroprevalence and detection of Human herpesvirus-8 (HHV-8) among healthy blood donors residing in Qatar | 2.6 | 1 | Citations (PDF) |
| 37 | Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions | 5.6 | 49 | Citations (PDF) |
| 38 | Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression | 9.2 | 602 | Citations (PDF) |
| 39 | Epidemiology of herpes simplex virus type 2 in the Middle East and North Africa: Systematic review, meta‐analyses, and meta‐regressions | 2.0 | 26 | Citations (PDF) |
| 40 | Epidemiological impact of public health interventions against diabetes in Qatar: mathematical modeling analyses | 1.8 | 7 | Citations (PDF) |
| 41 | Middle East respiratory syndrome coronavirus and the 2022 world cup football tournament in Qatar | 2.0 | 1 | Citations (PDF) |
| 42 | Treatment as prevention for hepatitis C virus in the Middle East and North Africa: a modeling study | 1.8 | 8 | Citations (PDF) |
| 43 | Epidemiology of herpes simplex virus type 1 in Canada: systematic review, meta-analyses, and meta-regressions | 1.8 | 17 | Citations (PDF) |
| 44 | Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study | 6.6 | 56 | Citations (PDF) |
| 45 | Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections | 2.0 | 30 | Citations (PDF) |
| 46 | Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study | 6.6 | 29 | Citations (PDF) |
| 47 | Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar | 2.2 | 10 | Citations (PDF) |
| 48 | Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study | 1.4 | 31 | Citations (PDF) |
| 49 | History of primary-series and booster vaccination and protection against Omicron reinfection | 8.1 | 20 | Citations (PDF) |
| 50 | Seroprevalence of hepatitis E virus (HEV) among male craft and manual workers in Qatar (2020–2021) | 2.4 | 6 | Citations (PDF) |
| 51 | SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study | 2.2 | 9 | Citations (PDF) |
| 52 | Patterns and trends of hepatitis C virus infection in Jordan: an observational study | 1.8 | 4 | Citations (PDF) |
| 53 | Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant | 3.7 | 48 | Citations (PDF) |
| 54 | Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections | 10.8 | 70 | Citations (PDF) |
| 55 | Impact of diabetes mellitus on tuberculosis epidemiology in Indonesia: A mathematical modeling analysis | 1.2 | 16 | Citations (PDF) |
| 56 | Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | 26.4 | 83 | Citations (PDF) |
| 57 | Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar | 26.4 | 118 | Citations (PDF) |
| 58 | Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2 | 1.5 | 1 | Citations (PDF) |
| 59 | Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO | 15.0 | 25 | Citations (PDF) |
| 60 | Protection against the Omicron Variant from Previous SARS-CoV-2 Infection | 26.4 | 443 | Citations (PDF) |
| 61 | Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar | 7.7 | 99 | Citations (PDF) |
| 62 | Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression | 46.9 | 1,200 | Citations (PDF) |
| 63 | Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | 26.4 | 382 | Citations (PDF) |
| 64 | First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017–2020 | 1.5 | 9 | Citations (PDF) |
| 65 | Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals | 1.4 | 26 | Citations (PDF) |
| 66 | Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant | 3.7 | 125 | Citations (PDF) |
| 67 | Modeling the population-level impact of treatment on COVID-19 disease and SARS-CoV-2 transmission | 1.3 | 7 | Citations (PDF) |
| 68 | Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization | 2.0 | 83 | Citations (PDF) |
| 69 | Analyzing inherent biases in SARS-CoV-2 PCR and serological epidemiologic metrics | 1.7 | 5 | Citations (PDF) |
| 70 | Reporting of RT-PCR cycle threshold (Ct) values during the first wave of COVID-19 in Qatar improved result interpretation in clinical and public health settings | 1.3 | 13 | Citations (PDF) |
| 71 | Impact of trends and gender disparity in obesity on future type 2 diabetes in Turkey: a mathematical modelling analysis | 1.2 | 15 | Citations (PDF) |
| 72 | Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections | 2.0 | 45 | Citations (PDF) |
| 73 | Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar | 10.8 | 231 | Citations (PDF) |
| 74 | Application of human RNase P normalization for the realistic estimation of SARS-CoV-2 viral load in wastewater: A perspective from Qatar wastewater surveillance | 4.7 | 30 | Citations (PDF) |
| 75 | Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | 26.4 | 529 | Citations (PDF) |
| 76 | HIV incidence and impact of interventions among female sex workers and their clients in the Middle East and north Africa: a modelling study | 5.9 | 23 | Citations (PDF) |
| 77 | Status of the HIV epidemic in key populations in the Middle East and north Africa: knowns and unknowns | 5.9 | 55 | Citations (PDF) |
| 78 | COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar | 2.4 | 61 | Citations (PDF) |
| 79 | COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar | 1.5 | 4 | Citations (PDF) |
| 80 | Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees | 1.9 | 8 | Citations (PDF) |
| 81 | Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage | 10.8 | 72 | Citations (PDF) |
| 82 | COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status | 7.7 | 32 | Citations (PDF) |
| 83 | Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar | 1.4 | 21 | Citations (PDF) |
| 84 | Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections | 3.3 | 21 | Citations (PDF) |
| 85 | Duration of immune protection of SARS-CoV-2 natural infection against reinfection | 2.0 | 96 | Citations (PDF) |
| 86 | Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants | 26.4 | 136 | Citations (PDF) |
| 87 | Covid-19 Vaccine Protection among Children and Adolescents in Qatar | 26.4 | 70 | Citations (PDF) |
| 88 | A multinational Delphi consensus to end the COVID-19 public health threat | 30.7 | 185 | Citations (PDF) |
| 89 | Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2 | 26.4 | 80 | Citations (PDF) |
| 90 | Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies | 2.7 | 37 | Citations (PDF) |
| 91 | Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection | 2.0 | 11 | Citations (PDF) |
| 92 | Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses | 2.7 | 12 | Citations (PDF) |
| 93 | Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study | 4.6 | 32 | Citations (PDF) |
| 94 | Forecasting the type 2 diabetes mellitus epidemic and the role of key risk factors in Oman up to 2050: Mathematical modeling analyses | 1.9 | 38 | Citations (PDF) |
| 95 | Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting | 3.7 | 164 | Citations (PDF) |
| 96 | Global epidemiology of
Neisseria gonorrhoeae
in infertile populations: systematic review, meta-analysis and metaregression | 1.1 | 46 | Citations (PDF) |
| 97 | Seroprevalence of West Nile Virus among Healthy Blood Donors from Different National Populations Residing in Qatar | 1.4 | 13 | Citations (PDF) |
| 98 | Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies | 1.4 | 27 | Citations (PDF) |
| 99 | A diabetes risk score for Qatar utilizing a novel mathematical modeling approach to identify individuals at high risk for diabetes | 2.7 | 17 | Citations (PDF) |
| 100 | Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays | 2.1 | 15 | Citations (PDF) |
| 101 | Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months | 1.6 | 24 | Citations (PDF) |
| 102 | Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic | 2.7 | 155 | Citations (PDF) |
| 103 | Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses | 0.5 | 34 | Citations (PDF) |
| 104 | Vulnerability of Syrian refugees in Lebanon to COVID-19: quantitative insights | 2.7 | 39 | Citations (PDF) |
| 105 | Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China | 1.9 | 28 | Citations (PDF) |
| 106 | Analytic Characterization of the Herpes Simplex Virus Type 2 Epidemic in the United States, 1950–2050 | 0.7 | 29 | Citations (PDF) |
| 107 | Epidemiology of herpes simplex virus type 2 in sub-Saharan Africa: Systematic review, meta-analyses, and meta-regressions | 6.6 | 54 | Citations (PDF) |
| 108 | SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar | 0.7 | 78 | Citations (PDF) |
| 109 | Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar | 2.7 | 97 | Citations (PDF) |
| 110 | Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses | 2.0 | 89 | Citations (PDF) |
| 111 | SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy | 6.6 | 168 | Citations (PDF) |
| 112 | Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out | 1.9 | 20 | Citations (PDF) |
| 113 | COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar | 5.6 | 157 | Citations (PDF) |
| 114 | Epidemiology of herpes simplex virus type 2 in Latin America and the Caribbean: systematic review, meta-analyses and metaregressions | 1.1 | 31 | Citations (PDF) |
| 115 | SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals | 2.4 | 98 | Citations (PDF) |
| 116 | Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population | 2.7 | 18 | Citations (PDF) |
| 117 | mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | 22.6 | 399 | Citations (PDF) |
| 118 | Epidemiology of herpes simplex virus type 2 in Asia: A systematic review, meta-analysis, and meta-regression | 2.0 | 22 | Citations (PDF) |
| 119 | Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar | 14.4 | 42 | Citations (PDF) |
| 120 | Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants | 26.4 | 969 | Citations (PDF) |
| 121 | Effect of multiple freeze–thaw cycles on the detection of anti-SARS-CoV-2 IgG antibodies | 1.3 | 10 | Citations (PDF) |
| 122 | Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar | 1.4 | 72 | Citations (PDF) |
| 123 | Do the selection criteria of internal medicine residency program predict resident performance? | 0.3 | 0 | Citations (PDF) |
| 124 | SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar | 2.7 | 63 | Citations (PDF) |
| 125 | Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination | 1.4 | 87 | Citations (PDF) |
| 126 | Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals | 2.7 | 39 | Citations (PDF) |
| 127 | SARS-CoV-2 infection rates in air passengers arriving in Qatar | 2.0 | 5 | Citations (PDF) |
| 128 | Characterizing epidemiology of prediabetes, diabetes, and hypertension in Qataris: A cross-sectional study | 1.5 | 18 | Citations (PDF) |
| 129 | SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women | 6.6 | 59 | Citations (PDF) |
| 130 | Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | 26.4 | 817 | Citations (PDF) |
| 131 | A systematic review of interventions to promote physical activity in six Gulf countries | 1.5 | 29 | Citations (PDF) |
| 132 | Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar | 14.4 | 161 | Citations (PDF) |
| 133 | The social and structural determinants of sexual and reproductive health and rights in migrants and refugees: a systematic review of reviews | 0.6 | 51 | Citations (PDF) |
| 134 | BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar | 22.6 | 422 | Citations (PDF) |
| 135 | Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections | 26.4 | 167 | Citations (PDF) |
| 136 | Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020 | 1.0 | 43 | Citations (PDF) |
| 137 | One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar | 2.8 | 73 | Citations (PDF) |
| 138 | Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant | 26.4 | 114 | Citations (PDF) |
| 139 | Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals | 2.0 | 23 | Citations (PDF) |
| 140 | Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study | 4.6 | 63 | Citations (PDF) |
| 141 | Characterising HIV/AIDS knowledge and attitudes in the Middle East and North Africa: Systematic review and data synthesis | 1.2 | 44 | Citations (PDF) |
| 142 | Key associations for hepatitis C virus genotypes in the Middle East and North Africa | 2.0 | 12 | Citations (PDF) |
| 143 | Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictions | 1.3 | 24 | Citations (PDF) |
| 144 | Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020 | 1.2 | 85 | Citations (PDF) |
| 145 | Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses | 1.9 | 28 | Citations (PDF) |
| 146 | HSV-2 as a biomarker of HIV epidemic potential in female sex workers: meta-analysis, global epidemiology and implications | 2.7 | 6 | Citations (PDF) |
| 147 | Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses | 1.9 | 104 | Citations (PDF) |
| 148 | Effect of subsidies on healthful consumption: a protocol for a systematic review update | 1.2 | 2 | Citations (PDF) |
| 149 | Interventions promoting physical activity among adults and children in the six Gulf Cooperation Council countries: protocol for a systematic review | 1.2 | 6 | Citations (PDF) |
| 150 | Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide | 1.5 | 40 | Citations (PDF) |
| 151 | Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050 | 2.7 | 46 | Citations (PDF) |
| 152 | Characterizing key attributes of COVID-19 transmission dynamics in China's original outbreak: Model-based estimations | 1.0 | 35 | Citations (PDF) |
| 153 | Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt | 2.8 | 23 | Citations (PDF) |
| 154 | The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa | 3.9 | 35 | Citations (PDF) |
| 155 | Hepatitis C Virus Infection in Populations With Liver‐Related Diseases in the Middle East and North Africa | 3.3 | 7 | Citations (PDF) |
| 156 | Child and adolescent injury burden in the eastern mediterranean region: Findings from the Global Burden of Disease 1990-2017 | 2.1 | 40 | Citations (PDF) |
| 157 | Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications | 1.7 | 24 | Citations (PDF) |
| 158 | Herpes simplex virus: global infection prevalence and incidence estimates, 2016 | 1.3 | 756 | Citations (PDF) |
| 159 | Seroprevalence of Herpes simplex virus types 1 and 2 in Indian and Filipino migrant populations in Qatar: a cross-sectional survey | 0.6 | 8 | Citations (PDF) |
| 160 | Can the COVID-19 pandemic still be suppressed? Putting essential pieces together | 0.3 | 4 | Citations (PDF) |
| 161 | The Epidemiology of Herpes Simplex Virus Type 1 in Asia: Systematic Review, Meta-analyses, and Meta-regressions | 3.7 | 96 | Citations (PDF) |
| 162 | Epidemiology of Chlamydia trachomatis in the Middle East and north Africa: a systematic review, meta-analysis, and meta-regression | 9.7 | 63 | Citations (PDF) |
| 163 | Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 | 1.3 | 1,442 | Citations (PDF) |
| 164 | Herpes simplex virus type 1 epidemiology in Africa: Systematic review, meta-analyses, and meta-regressions | 2.5 | 47 | Citations (PDF) |
| 165 | Epidemiology of Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics | 2.4 | 33 | Citations (PDF) |
| 166 | HIV epidemiology among female sex workers and their clients in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions | 4.4 | 60 | Citations (PDF) |
| 167 | Forecasting the impact of diabetes mellitus on tuberculosis disease incidence and mortality in India | 2.4 | 20 | Citations (PDF) |
| 168 | Characterization of the hepatitis C virus epidemic in Pakistan | 1.7 | 40 | Citations (PDF) |
| 169 | Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North Africa | 2.2 | 15 | Citations (PDF) |
| 170 | Analytical Exploration of Potential Pathways by which Diabetes Mellitus Impacts Tuberculosis Epidemiology | 2.7 | 16 | Citations (PDF) |
| 171 | Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States | 1.5 | 71 | Citations (PDF) |
| 172 | Global epidemiology ofNeisseria gonorrhoeaein infertile populations: protocol for a systematic review | 1.2 | 11 | Citations (PDF) |
| 173 | Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: Systematic review and meta-analytics | 1.5 | 48 | Citations (PDF) |
| 174 | Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions | 4.4 | 125 | Citations (PDF) |
| 175 | Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests | 3.3 | 28 | Citations (PDF) |
| 176 | Seriously misleading results using inverse of Freeman‐Tukey double arcsine transformation in meta‐analysis of single proportions | 3.1 | 568 | Citations (PDF) |
| 177 | Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions | 2.7 | 56 | Citations (PDF) |
| 178 | The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses | 2.7 | 35 | Citations (PDF) |
| 179 | Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar | 1.5 | 30 | Citations (PDF) |
| 180 | Does infection withChlamydia trachomatisinduce long-lasting partial immunity? Insights from mathematical modelling | 1.1 | 25 | Citations (PDF) |
| 181 | Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections | 1.2 | 23 | Citations (PDF) |
| 182 | Preventing type 2 diabetes mellitus in Qatar by reducing obesity, smoking, and physical inactivity: mathematical modeling analyses | 1.4 | 26 | Citations (PDF) |
| 183 | Negative epidemiological association between HSV-1 and HSV-2 infections | 2.4 | 7 | Citations (PDF) |
| 184 | Reply to Brijwal et al | 3.7 | 0 | Citations (PDF) |
| 185 | Herpes Simplex Virus Type 2 Seroprevalence Among Different National Populations of Middle East and North African Men | 0.8 | 31 | Citations (PDF) |
| 186 | HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis | 2.2 | 40 | Citations (PDF) |
| 187 | Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis | 1.1 | 28 | Citations (PDF) |
| 188 | Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions | 2.7 | 163 | Citations (PDF) |
| 189 | Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan | 1.3 | 33 | Citations (PDF) |
| 190 | Mapping of new HIV infections in Morocco and impact of select interventions | 1.4 | 22 | Citations (PDF) |
| 191 | The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses | 2.7 | 109 | Citations (PDF) |
| 192 | Trends and Predictors of Syphilis Prevalence in the General Population: Global Pooled Analyses of 1103 Prevalence Measures Including 136 Million Syphilis Tests | 3.7 | 72 | Citations (PDF) |
| 193 | Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns | 2.0 | 51 | Citations (PDF) |
| 194 | Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population | 2.2 | 16 | Citations (PDF) |
| 195 | Estimating the annual risk of HIV transmission within HIV sero-discordant couples in sub-Saharan Africa | 1.4 | 11 | Citations (PDF) |
| 196 | Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach | 2.0 | 59 | Citations (PDF) |
| 197 | HIV and herpes simplex virus type 2 epidemiological synergy: misguided observational evidence? A modelling study | 1.1 | 42 | Citations (PDF) |
| 198 | Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar | 2.0 | 41 | Citations (PDF) |
| 199 | Use of routine HIV testing data for early detection of emerging HIV epidemics in high-risk subpopulations: A concept demonstration study | 0.8 | 4 | Citations (PDF) |
| 200 | Temporal evolution of HIV sero-discordancy patterns among stable couples in sub-Saharan Africa | 1.5 | 3 | Citations (PDF) |
| 201 | A signature for biological heterogeneity in susceptibility to HIV infection? | 0.8 | 5 | Citations (PDF) |
| 202 | Hepatitis C virus infection spontaneous clearance: Has it been underestimated? | 1.4 | 34 | Citations (PDF) |
| 203 | Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 | 46.9 | 881 | Citations (PDF) |
| 204 | Syphilis prevalence trends in adult women in 132 countries – estimations using the Spectrum Sexually Transmitted Infections model | 2.7 | 45 | Citations (PDF) |
| 205 | The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses | 1.6 | 113 | Citations (PDF) |
| 206 | Global population-level association between herpes simplex virus 2 prevalence and HIV prevalenceAids, 2018, 32, 1343-1352 | 1.5 | 41 | Citations (PDF) |
| 207 | Sexual network drivers of HIV and herpes simplex virus type 2 transmissionAids, 2017, 31, 1721-1732 | 1.5 | 43 | Citations (PDF) |
| 208 | Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 46.9 | 682 | Citations (PDF) |
| 209 | Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 46.9 | 1,869 | Citations (PDF) |
| 210 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 46.9 | 7,167 | Citations (PDF) |
| 211 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 46.9 | 2,217 | Citations (PDF) |
| 212 | Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 | 46.9 | 325 | Citations (PDF) |
| 213 | Trends in Adult Chlamydia and Gonorrhea Prevalence, Incidence and Urethral Discharge Case Reporting in Morocco over 1995–2015—Estimates Using the Spectrum-Sexually Transmitted Infection Model | 0.8 | 25 | Citations (PDF) |
| 214 | Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts | 1.3 | 17 | Citations (PDF) |
| 215 | Estimating prevalence trends in adult gonorrhoea and syphilis in low- and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016 | 1.1 | 43 | Citations (PDF) |
| 216 | The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990-2013 | 1.5 | 143 | Citations (PDF) |
| 217 | Urban Chikungunya in the Middle East and North Africa: A systematic review | 2.0 | 32 | Citations (PDF) |
| 218 | Human Papillomavirus (HPV) Infection: Molecular Epidemiology, Genotyping, Seroprevalence and Associated Risk Factors among Arab Women in Qatar | 1.5 | 38 | Citations (PDF) |
| 219 | Could Circumcision of HIV-Positive Males Benefit Voluntary Medical Male Circumcision Programs in Africa? Mathematical Modeling Analysis | 1.5 | 10 | Citations (PDF) |
| 220 | The prevalence and incidence of active syphilis in women in Morocco, 1995-2016: Model-based estimation and implications for STI surveillance | 1.5 | 14 | Citations (PDF) |
| 221 | Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions | 1.5 | 34 | Citations (PDF) |
| 222 | Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis | 1.5 | 271 | Citations (PDF) |
| 223 | Geographical Patterns of HIV Sero-Discordancy in High HIV Prevalence Countries in Sub-Saharan Africa | 2.0 | 13 | Citations (PDF) |
| 224 | The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 | 46.9 | 1,231 | Citations (PDF) |
| 225 | Multiplex Polymerase Chain Reaction for Detection of Gastrointestinal Pathogens in Migrant Workers in Qatar | 0.3 | 12 | Citations (PDF) |
| 226 | Population sexual behavior and HIV prevalence in Sub-Saharan Africa: missing links? | 1.4 | 7 | Citations (PDF) |
| 227 | Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence | 1.4 | 69 | Citations (PDF) |
| 228 | Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 46.9 | 1,907 | Citations (PDF) |
| 229 | Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 46.9 | 5,813 | Citations (PDF) |
| 230 | Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 46.9 | 6,353 | Citations (PDF) |
| 231 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 46.9 | 4,825 | Citations (PDF) |
| 232 | Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 46.9 | 680 | Citations (PDF) |
| 233 | Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 | 46.9 | 508 | Citations (PDF) |
| 234 | Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 9.7 | 185 | Citations (PDF) |
| 235 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 | 5.9 | 504 | Citations (PDF) |
| 236 | HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis | 2.1 | 30 | Citations (PDF) |
| 237 | Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis | 2.2 | 48 | Citations (PDF) |
| 238 | Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013 | 4.6 | 572 | Citations (PDF) |
| 239 | Dengue in the Middle East and North Africa: A Systematic Review | 2.0 | 94 | Citations (PDF) |
| 240 | Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis | 1.5 | 59 | Citations (PDF) |
| 241 | Epidemiology and Ecology of Arboviruses in the Middle East and North Africa: A Systematic Review | 0.7 | 1 | Citations (PDF) |
| 242 | Association between HCV infection and diabetes type 2 in Egypt: is it time to split up? | 1.1 | 14 | Citations (PDF) |
| 243 | The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis | 1.4 | 38 | Citations (PDF) |
| 244 | Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North AfricaAids, 2015, 29, 1701-1710 | 1.5 | 25 | Citations (PDF) |
| 245 | The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis | 1.5 | 54 | Citations (PDF) |
| 246 | A Reevaluation of the Voluntary Medical Male Circumcision Scale-Up Plan in Zimbabwe | 1.5 | 29 | Citations (PDF) |
| 247 | Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia | 1.5 | 49 | Citations (PDF) |
| 248 | Are Geographical “Cold Spots” of Male Circumcision Driving Differential HIV Dynamics in Tanzania? | 1.8 | 10 | Citations (PDF) |
| 249 | Prevention of type II diabetes mellitus in Qatar: Who is at risk? | 0.3 | 16 | Citations (PDF) |
| 250 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 46.9 | 5,681 | Citations (PDF) |
| 251 | Dynamics of non-cohabiting sex partnering in sub-Saharan Africa: a modelling study with implications for HIV transmission | 1.1 | 24 | Citations (PDF) |
| 252 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition | 46.9 | 1,758 | Citations (PDF) |
| 253 | Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt | 9.6 | 46 | Citations (PDF) |
| 254 | The Epidemiology of Hepatitis C Virus in the Maghreb Region: Systematic Review and Meta-Analyses | 1.5 | 54 | Citations (PDF) |
| 255 | Sources of HIV incidence among stable couples in sub‐Saharan Africa | 2.2 | 74 | Citations (PDF) |
| 256 | Molecular epidemiology and genotype distribution of Human Papillomavirus (HPV) among Arab women in the state of Qatar | 4.8 | 43 | Citations (PDF) |
| 257 | HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis | 4.6 | 157 | Citations (PDF) |
| 258 | The emerging face of the HIV epidemic in the Middle East and North Africa | 1.8 | 76 | Citations (PDF) |
| 259 | Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications | 9.6 | 65 | Citations (PDF) |
| 260 | Could there have been substantial declines in sexual risk behavior across sub-Saharan Africa in the mid-1990s? | 1.3 | 54 | Citations (PDF) |
| 261 | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 46.9 | 842 | Citations (PDF) |
| 262 | Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis | 3.7 | 445 | Citations (PDF) |
| 263 | The risk of HIV transmission within HIV-1 sero-discordant couples appears to vary across sub-Saharan Africa | 1.3 | 40 | Citations (PDF) |
| 264 | Spatial variability in HIV prevalence declines in several countries in sub-Saharan Africa | 2.4 | 31 | Citations (PDF) |
| 265 | Use of agent-based simulations to design and interpret HIV clinical trials | 4.5 | 13 | Citations (PDF) |
| 266 | How does population viral load vary with the evolution of a large HIV epidemic in sub-Saharan Africa? | 1.5 | 5 | Citations (PDF) |
| 267 | The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis | 1.7 | 321 | Citations (PDF) |
| 268 | Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa | 2.0 | 86 | Citations (PDF) |
| 269 | Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? | 1.5 | 32 | Citations (PDF) |
| 270 | Prevalence ofChlamydia trachomatisinfection in the general population of women in Qatar | 1.1 | 20 | Citations (PDF) |
| 271 | The distribution of new HIV infections by mode of exposure in Morocco | 1.1 | 51 | Citations (PDF) |
| 272 | External infections contribute minimally to HIV incidence among HIV sero-discordant couples in sub-Saharan Africa | 1.1 | 21 | Citations (PDF) |
| 273 | Characterising the progress in HIV/AIDS research in the Middle East and North Africa | 1.1 | 35 | Citations (PDF) |
| 274 | Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa | 1.5 | 43 | Citations (PDF) |
| 275 | Prevention during the epidemiologic shift to chronic illness: a case control study of risk factors associated with cardiovascular disease in Qatar | 0.0 | 3 | Citations (PDF) |
| 276 | Characterizing the Copts in Egypt: Demographic, socioeconomic and health indicators | 0.2 | 4 | Citations (PDF) |
| 277 | Understanding the Potential Impact of a Combination HIV Prevention Intervention in a Hyper-Endemic Community | 1.5 | 38 | Citations (PDF) |
| 278 | An Apparent Lack of Epidemiologic Association between Hepatitis C Virus Knowledge and the Prevalence of Hepatitis C Infection in a National Survey in Egypt | 1.5 | 20 | Citations (PDF) |
| 279 | Understanding the modes of tranmission model of new HIV infection and its use in prevention planning | 1.3 | 63 | Citations (PDF) |
| 280 | HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling for Public Health Decision-Making in All Modes of Prevention and Evaluation | 4.6 | 41 | Citations (PDF) |
| 281 | Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa | 1.1 | 88 | Citations (PDF) |
| 282 | Time to Refocus on HSV Interventions for HIV Prevention? | 2.2 | 10 | Citations (PDF) |
| 283 | Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions | 1.1 | 85 | Citations (PDF) |
| 284 | Are HIV Epidemics among Men Who Have Sex with Men Emerging in the Middle East and North Africa?: A Systematic Review and Data Synthesis | 4.6 | 137 | Citations (PDF) |
| 285 | HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa | 1.1 | 33 | Citations (PDF) |
| 286 | Estimating HIV Incidence Rate among Stable Sexual Partnerships in Sub-Saharan Africa | 0.0 | 0 | Citations (PDF) |
| 287 | HIV Molecular Epidemiology in the Middle East and North Africa: Understanding the Virus Transmission Patterns | 0.0 | 0 | Citations (PDF) |
| 288 | Epidemiology of HIV infection in the Middle East and North Africa | 1.5 | 143 | Citations (PDF) |
| 289 | Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt | 0.0 | 1 | Citations (PDF) |
| 290 | Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes | 5.2 | 128 | Citations (PDF) |
| 291 | Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt | 5.2 | 168 | Citations (PDF) |
| 292 | HIV/AIDS in the Middle East and North Africa: new study methods, results, and implications for prevention and care | 1.5 | 33 | Citations (PDF) |
| 293 | HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa | 1.3 | 67 | Citations (PDF) |
| 294 | HIV prevention policy in the Middle East and North Africa: Entangled dilemmas | 0.0 | 3 | Citations (PDF) |
| 295 | Population Level Impact of an Imperfect Prophylactic Vaccine for Herpes Simplex Virus-2 | 0.8 | 43 | Citations (PDF) |
| 296 | Nascent HIV epidemics among men who have sex with men appear to be emerging in the Middle East and North Africa | 0.0 | 1 | Citations (PDF) |
| 297 | Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics | 5.2 | 343 | Citations (PDF) |
| 298 | Frequent Release of Low Amounts of Herpes Simplex Virus from Neurons: Results of a Mathematical Model | 8.7 | 124 | Citations (PDF) |
| 299 | Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level | 1.3 | 27 | Citations (PDF) |
| 300 | Twenty-Five Years of HIV: Lessons for Low Prevalence Scenarios | 1.2 | 9 | Citations (PDF) |
| 301 | Persisting with prevention: The importance of adherence for HIV prevention | 2.5 | 58 | Citations (PDF) |
| 302 | Measuring the public-health impact of candidate HIV vaccines as part of the licensing process | 9.2 | 29 | Citations (PDF) |
| 303 | No HIV stage is dominant in driving the HIV epidemic in sub-Saharan AfricaAids, 2008, 22, 1055-1061 | 1.5 | 91 | Citations (PDF) |
| 304 | Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa | 1.5 | 125 | Citations (PDF) |
| 305 | Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa | 1.5 | 238 | Citations (PDF) |
| 306 | Analytic Insights Into the Population Level Impact of Imperfect Prophylactic HIV Vaccines | 1.2 | 26 | Citations (PDF) |
| 307 | Mass of the nucleon in a chiral quark-diquark model | 2.1 | 8 | Citations (PDF) |
| 308 | The impact of cross-immunity, mutation and stochastic extinction on pathogen diversity | 1.6 | 52 | Citations (PDF) |
| 309 | Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong | 46.9 | 870 | Citations (PDF) |
| 310 | TDPAC study of structural disorder in metamict zircon | 1.4 | 11 | Citations (PDF) |
| 311 | Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19 | 2.4 | 88 | Citations (PDF) |
| 312 | A regional picture: MENA's HIV map | 0.0 | 3 | Citations (PDF) |
| 313 | Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar’s experience | 2.4 | 14 | Citations (PDF) |
| 314 | Hepatitis B Virus in Jordan: Prevalence, Incidence and Clearance From Cross‐Sectional and Cohort Studies | 1.3 | 1 | Citations (PDF) |
| 315 | Quantifying population-level sexual risk behavior through HSV-2 transmission dynamics in the United States, 1950–2020 | 2.7 | 4 | Citations (PDF) |
| 316 | Global childhood diarrhoea prevalence and its determinants: a systematic meta-analytic assessment, 1985–2024 | 6.6 | 8 | Citations (PDF) |
| 317 | Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in Qatar | 2.7 | 0 | Citations (PDF) |
| 318 | Estimating SARS-CoV-2 infection incidence and detection rates: Demonstrating a novel surveillance method | 1.7 | 0 | Citations (PDF) |
| 319 | A novel surveillance-based method for estimating the waning of immunity following natural infection | 1.7 | 0 | Citations (PDF) |
| 320 | Global Estimates of COVID‐19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis | 2.2 | 4 | Citations (PDF) |
| 321 | Two-dimensional nanomaterials for infection control: A comprehensive review | 2.6 | 3 | Citations (PDF) |
| 322 | MSM and HIV in the Middle East and north Africa | 5.9 | 1 | Citations (PDF) |
| 323 | Herpes Simplex Virus Type 2 Screening in Persons with and Without HIV: Evidence, Challenges, and Future Directions | 2.4 | 6 | Citations (PDF) |
| 324 | Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in Canada, 1969–2025: a systematic review and meta-analysis | 2.1 | 1 | Citations (PDF) |
| 325 | Global epidemiology of neonatal herpes: systematic review, meta-analyses, and meta-regressions | 2.4 | 5 | Citations (PDF) |
| 326 | Beyond aggregate estimates: stratified self-controlled case series analyses and insights into COVID-19 vaccine safety | 3.2 | 0 | Citations (PDF) |
| 327 | Sex-specific biological susceptibility and sexual mixing patterns in herpes simplex virus type 2 transmission: a mathematical modeling study | 1.5 | 3 | Citations (PDF) |
| 328 | Mathematical modeling of the population-level impact of hypothetical herpes simplex virus type 2 curative therapy | 3.1 | 1 | Citations (PDF) |
| 329 | Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis | 8.1 | 2 | Citations (PDF) |
| 330 | National and regional analysis of HIV transmission dynamics in Morocco: a mathematical modelling study | 5.9 | 0 | Citations (PDF) |
| 331 | Factors associated with hypoglycemic or hyperglycemic events during Ramadan among persons with diabetes in Qatar | 2.9 | 0 | Citations (PDF) |
| 332 | Syphilis epidemiology in Jordan: prevalence, incidence, and seroreversion from 15 years of laboratory-based data | 2.7 | 0 | Citations (PDF) |
| 333 | Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in sub-Saharan Africa, 1964–2025: Systematic review, meta-analyses, and meta-regressions | 4.6 | 0 | Citations (PDF) |
| 334 | Epidemiology of Neisseria gonorrhoeae in Jordan: prevalence, incidence, and clearance from a national laboratory dataset, 2014–2025 | 2.1 | 0 | Citations (PDF) |
| 335 | Epidemiology of
Treponema pallidum
,
Chlamydia trachomatis
,
Neisseria gonorrhoeae
and
Trichomonas vaginalis
among forcibly displaced populations: a global systematic review and meta-analysis | 2.7 | 0 | Citations (PDF) |
| 336 | Epidemiology of Chlamydia trachomatis in Canada: systematic review and meta-analysis, 1981–2025 | 2.0 | 0 | Citations (PDF) |
| 337 | Global and regional trends in herpes simplex virus type 2 infection and genital ulcer disease 0, 1, | | 1 | Citations (PDF) |
